LATEST ISSUE: WINTER 2017/18
"R&D productivity remains an ongoing concern. Artificial Intelligence and the accompanying analytics are now so advanced that these tools promise t...
Read MoreBy Dr Julia Schuler and Dr Louise Brackenbury
For many years, immunology and oncology operated as separate disciplines within drug discovery. However, recent advances in immuno-oncology (IO) ha...
Read MoreIncreasing clinical success by implementing improved methodologies in early phase drug discovery. Using primary cells and 3D culture models to enha...
Read MoreAdoption of a scientific informatics system is essential to the success of every drug discovery organisation.
Read MoreApplication of new assay technologies to shed light on kinase drug discovery.
Read MoreBy Ibis Sanchez- Serrano, Dr Tom Pfeifer and Dr Rathnam Chaguturu
This article is part 1 of 2, and covers tools, technologies and the core model.
Read MoreBy Dr Paul Avery and Dr Richard Massey
CRISPR-Cas9 has rapidly transformed our ability to perform targeted gene editing. While the technique has received much interest for its potential ...
Read MoreBy Dr Azusa Tanaka and Dr Michael Seiler
Regulatory approval of CAR-T cell therapies in 2017 placed the spotlight on immunotherapy approaches that use live cells to attack tumours â a ma...
Read MoreProduct & Industry News
ADC Bio secures £1.14m investment from Downing LLP to finance innovative bioconjugation and US expansion. Funding earmarked for US market pen...
Read MoreThe prestigious award is in recognition of Cobraâs commercial success in providing services to its global customer base.
Read MoreEndomag, the surgical guidance company, today announced it has received the Queenâs Award for Enterprise in Innovation for 2018. The Award recogn...
Read MoreHelperby Therapeutics announces phase 1 results demonstrating multiple benefits of its unique combination antibiotic therapy - effective against th...
Read MoreTechnology will be used to progress Fusionâs pipeline of alpha therapeutics for the treatment of cancers.
Read MoreTorque Presents Preclinical Data at AACR Demonstrating that Deep-Primed IL-15 and Deep-Primed IL-12 Anchored to T Cells are Superior to Systemicall...
Read MoreEvents
Dates: 24-25 May 2018
Venue: Cambridge, UK
Dates: 24-25 May 2018
Venue: Cambridge, UK
Dates: 5-6 June 2018
Venue: Rotterdam, The Netherlands
Dates: 5-6 June 2018
Venue: Rotterdam, The Netherlands
Dates: 5-6 June 2018
Venue: Rotterdam, The Netherlands